A UC San Diego study found that online e-cigarette retailers are not sticking to regulations on shipping and flavor restrictions. Researchers and experts discuss the concerning findings.
A new strain of mpox has been confirmed on American shores after a traveler returned to California from a visit to Africa, but risk to the public remains "very low."
Nursing students at Goldfarb School of Nursing use virtual reality to practice clinical skills in a simulated environment, preparing for real-world health care challenges amid a growing shortage.
The number of people living with diabetes worldwide has quadrupled in the past two decades, with 830 million people diagnosed as of 2022. Experts weigh in on the risk.
Amid the ongoing McDonald's E. coli investigation, Fox News Digital spoke with several food safety experts about the most prevalent foodborne illnesses and how to prevent them.
Prediabetes is almost always a precursor to type 2 diabetes — but it doesn’t have to lead to that outcome. Experts share healthy steps to reverse the condition.
A breast cancer vaccine could be closer to reality, according to Cleveland Clinic, as its researchers have announced some encouraging results. Researchers and doctors weigh in.
Dave Coulier, 65, announced on Tuesday that he has stage 3 non-Hodgkin lymphoma. An oncologist explains the symptoms, treatment and prognosis of the aggressive blood cancer.
Recent outbreaks of Legionnaires’ disease have been linked to cruise ship hot tubs, according to CDC reports. Infectious disease experts discuss symptoms and prevention.
The Fox News Health Newsletter brings you trending and important stories about health care, drug developments, mental health issues, real people's triumphs over medical struggles, and more.
The U.S. Food and Drug Administration (FDA) has authorized a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine, Bivalent for children 6 months through 4 years of age.
Researchers from Dartmouth College have reported the first instance of prosopagnosia (otherwise known as “face blindness”) as a symptom following COVID-19 infection.
For those suffering from primary bone cancer, a promising new medication called CADD522 may be on the horizon. In early tests, it extended survival and reduced tumor growth.
Getting insufficient sleep in the days surrounding a vaccination could weaken its effectiveness, particularly for men, a new study has found.